stock offering
Genetic Technologies to Raise A$5M in Direct Stock Offering
The firm said several institutional investors had inked definitive agreements for the purchase and sale of 3,846,155 American Depositary Shares.
MDxHealth Prices $40M Public Offering
The diagnostics company is offering 10 million American Depositary Shares at $4.00 per share, with an option to underwriters to buy another 1.5 million.
GeneDx to Raise $150M in Public and Direct Stock Offerings
Expected to close Jan. 31, the stock sales are intended to help the firm build up working capital, repay debts, and make strategic investments.
MDx Firm OpGen Prices $7.5M Public Offering
The Maryland-based firm announced the public offering of common stock and warrants one day after announcing a 1-for-20 reverse stock split to help regain Nasdaq compliance.
Biodesix to Sell $35.1M in Common Stock, Inks $50M Loan Agreement
Earlier this month, the Boulder, Colorado-based diagnostics firm reported ending the third quarter with $15.2 million in cash and cash equivalents.